Technology · Biotechnology R&D expenditure
Canada's expenditure on biotechnology research and development in 2026 is 800 M $, ranking 6th among 197 countries. The zero value in the ranking reflects not a lack of investment but the accounting methodology: a significant portion of funding is distributed through university grants and private foundations. The largest biotech clusters—in Montreal, Toronto, and Vancouver—attract hundreds of millions of dollars annually.
Data for 2026 · unit: $
Position
#6 / 197
Canada world ranking
Country position on the scale from last to first place for this indicator.
CA
#6
#197#1
Trend
Change over time
Change in indicator over the available period.
100 M
1990
500 M
2000
1.2 B
2010
2 B
2020
750 M
2025
800 M
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Canada stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Canada — how much?
Based on 2026 data — 800 M $. This is rank #6 out of 197 countries.
What is Canada's rank by Biotechnology R&D expenditure?
Canada ranks #6 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Canada?
Over the available period the indicator changed from 100 M to 800 M $.